These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 31828062

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    Cro S, Cornelius V, Capon F, Barker J, Burden D, Griffiths C, Lachmann HJ, McAteer H, Patel P, Pink A, Reynolds N, Warren R, Smith C.
    ; 2022 03. PubMed ID: 35377574
    [Abstract] [Full Text] [Related]

  • 43. Nail Psoriasis: A Systematic Evaluation in 313 Children with Psoriasis.
    Pourchot D, Bodemer C, Phan A, Bursztejn AC, Hadj-Rabia S, Boralevi F, Miquel J, Hubiche T, Puzenat E, Souillet AL, Kupfer I, Piram M, Beauchet A, Mahé E, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique.
    Pediatr Dermatol; 2017 Jan; 34(1):58-63. PubMed ID: 27873356
    [Abstract] [Full Text] [Related]

  • 44. HL-A antigens in patients with persistent palmoplantar pustulosis and pustular psoriasis.
    Karvonen J, Tiilikainen A, Lassus A.
    Ann Clin Res; 1975 Apr; 7(2):112-5. PubMed ID: 1181975
    [Abstract] [Full Text] [Related]

  • 45. Comparison of NAPSI and N-NAIL for evaluation of fingernail psoriasis in patients with moderate-to-severe plaque psoriasis treated using ustekinumab.
    Kim BR, Yang S, Choi CW, Youn SW.
    J Dermatolog Treat; 2019 Mar; 30(2):123-128. PubMed ID: 29757042
    [Abstract] [Full Text] [Related]

  • 46. Clinical parameters associated with severity of nail psoriasis and therapeutic efficacy.
    You Z, Yang H, Ran Y.
    Eur J Dermatol; 2020 Aug 01; 30(4):362-371. PubMed ID: 32969797
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Interobserver reliability of the Nail Psoriasis Severity Index.
    Aktan S, Ilknur T, Akin C, Ozkan S.
    Clin Exp Dermatol; 2007 Mar 01; 32(2):141-4. PubMed ID: 17137477
    [Abstract] [Full Text] [Related]

  • 49. Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.
    Sarıkaya Solak S, Kara Polat A, Kilic S, Oguz Topal I, Saricaoglu H, Karadag AS, Canpolat F, Kartal SP, Deveci BN, Kacar N, Polat Ekinci A, Guner R, Polat M, Dogan G, Guler Ozden M, Bulbul Baskan E, Ozaydin Yavuz G, Adisen E, Gulekon A, Tanribilir ME, Yilmaz O, Akman Karakas A, Ozturk P, Didar Balci D, Gonulal M, Yondem H, Turel Ermertcan A, Sendur N, Topyildiz H, Korkmaz S, Alpsoy E.
    Clin Exp Dermatol; 2022 Jan 01; 47(1):63-71. PubMed ID: 34236713
    [Abstract] [Full Text] [Related]

  • 50. [Assessment of psoriatic nail lesions therapy by means of nail psoriasis severity index].
    Tsiskarishvili NV, Katsitadze AG, Tsiskarishvili NI.
    Georgian Med News; 2011 Oct 01; (199):43-7. PubMed ID: 22155805
    [Abstract] [Full Text] [Related]

  • 51. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
    Rigopoulos D, Gregoriou S, Daniel Iii CR, Belyayeva H, Larios G, Verra P, Stamou C, Kontochristopoulos G, Avgerinou G, Katsambas A.
    Dermatology; 2009 Oct 01; 218(4):338-41. PubMed ID: 19212110
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. A modified approach to the histologic diagnosis of onychomycosis.
    Chang A, Wharton J, Tam S, Kovich OI, Kamino H.
    J Am Acad Dermatol; 2007 Nov 01; 57(5):849-53. PubMed ID: 17939937
    [Abstract] [Full Text] [Related]

  • 54. Ultrasound Assessment of Changes in Nails in Psoriasis and Psoriatic Arthritis.
    Krajewska-Włodarczyk M, Owczarczyk-Saczonek A, Placek W, Wojtkiewicz M, Wiktorowicz A, Wojtkiewicz J.
    Biomed Res Int; 2018 Nov 01; 2018():8251097. PubMed ID: 30271786
    [Abstract] [Full Text] [Related]

  • 55. A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis.
    Ortonne JP, Paul C, Berardesca E, Marino V, Gallo G, Brault Y, Germain JM.
    Br J Dermatol; 2013 May 01; 168(5):1080-7. PubMed ID: 23013207
    [Abstract] [Full Text] [Related]

  • 56. Nail involvement in psoriatic arthritis.
    Sobolewski P, Walecka I, Dopytalska K.
    Reumatologia; 2017 May 01; 55(3):131-135. PubMed ID: 28769136
    [Abstract] [Full Text] [Related]

  • 57. Diagnosis of nail psoriasis: importance of biopsy and histopathology.
    Grover C, Reddy BS, Uma Chaturvedi K.
    Br J Dermatol; 2005 Dec 01; 153(6):1153-8. PubMed ID: 16307651
    [Abstract] [Full Text] [Related]

  • 58. Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1.
    Rich P, Bourcier M, Sofen H, Fakharzadeh S, Wasfi Y, Wang Y, Kerkmann U, Ghislain PD, Poulin Y, PHOENIX 1 investigators.
    Br J Dermatol; 2014 Feb 01; 170(2):398-407. PubMed ID: 24117389
    [Abstract] [Full Text] [Related]

  • 59. Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study.
    Hagforsen E, Michaëlsson K, Lundgren E, Olofsson H, Petersson A, Lagumdzija A, Hedstrand H, Michaëlsson G.
    Acta Derm Venereol; 2005 Feb 01; 85(3):225-32. PubMed ID: 16040407
    [Abstract] [Full Text] [Related]

  • 60. Extra-palmoplantar lesions associated with palmoplantar pustulosis.
    Yamamoto T.
    J Eur Acad Dermatol Venereol; 2009 Nov 01; 23(11):1227-32. PubMed ID: 19453807
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.